- Home
- BLFS vs ASTH Comparison
BLFS vs ASTH Comparison
Compare BLFS & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLFS | ASTH |
|---|---|---|
| Founded | 1987 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 1989 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLFS | ASTH |
|---|---|---|
| Price | $24.61 | $20.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $31.50 | ★ $43.00 |
| AVG Volume (30 Days) | 352.6K | ★ 503.9K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | $100,144,000.00 | ★ $2,896,452,000.00 |
| Revenue This Year | $20.67 | $58.37 |
| Revenue Next Year | $14.13 | $25.48 |
| P/E Ratio | ★ N/A | $110.97 |
| Revenue Growth | ★ 87.53 | 68.17 |
| 52 Week Low | $19.10 | $20.12 |
| 52 Week High | $29.62 | $41.74 |
Technical Indicators
Market Signals| Indicator | BLFS | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 40.40 | 32.57 |
| Support Level | $24.68 | $21.75 |
| Resistance Level | $25.96 | $23.23 |
| Average True Range (ATR) | 1.05 | 1.08 |
| MACD | -0.08 | 0.14 |
| Stochastic Oscillator | 20.73 | 25.07 |
Price Performance
Historical ComparisonAbout BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.